TITLE

Do Well by Doing Good

AUTHOR(S)
Katen, Karen
PUB. DATE
October 2006
SOURCE
Leadership Excellence Essentials;Oct2006, Vol. 23 Issue 10, p6
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article discusses ethical issues in the pharmaceutical industry. It addresses the effect of business purpose and higher mission on morals. Problems concerning profit motive in the industry are addressed. Moreover, the impact of profit on the pharmaceutical industry is tackled. The role of medicines in decreasing overall healthcare cost is also discussed.
ACCESSION #
22713994

 

Related Articles

  • Championing Ethics: Industry Viewpoint. Menon, Suresh; Rai, Kamala // Perspectives in Clinical Research;Jan-Mar2013, Vol. 4 Issue 1, p33 

    The article explores ethics related to clinical research from the viewpoint of the pharmaceutical industry, which sponsors major clinical development projects. The industry views drug development as helping to improve healthcare and reduce its cost. The industry is aligned to the ethical...

  • PHARMACEUTICAL STRESS FROM FRAUD AND DECEIT.  // Health & Stress;Mar2008, Issue 3, p1 

    The article focuses on how large pharmaceutical companies have brought disturbance in their quest for higher revenues that have made them the most profitable industry in the U.S. The drugs' inflation rate was cited as the main reason for the increase of health costs and insurance payments....

  • We hate Big Pharma--but we sure love drugs. Colvin, Geoffrey // Fortune International (Europe);12/27/2004, Vol. 150 Issue 12, p28 

    Offers a look at the use of prescription drugs in the U.S. and public opinion of the pharmaceutical industry. Report that many Americans are critical of the pharmaceutical industry due to scandals involving drug safety, side effects, and drug prices; Impact of increased drug usage in increased...

  • We hate Big Pharma--but we sure love drugs. Colvin, Geoffrey // Fortune;12/27/2004, Vol. 150 Issue 13, p56 

    Offers a look at the use of prescription drugs in the U.S. and public opinion of the pharmaceutical industry. Report that many Americans are critical of the pharmaceutical industry due to scandals involving drug safety, side effects, and drug prices; Impact of increased drug usage in increased...

  • WLF: leave ethics out of approvals. J. G. D. // Medical Marketing & Media;May2006, Vol. 41 Issue 5, p17 

    The article focuses on two senior officers of the American Council on Science and Health's response to an article in the "Baltimore Sun" about bioethicists and environmentalists' call for the U.S. Food and Drug Administration (FDA) to consider other unscientific factors when deciding a product...

  • How to make the prices of new drugs fairer. Sotelo, Julio // BMJ: British Medical Journal (International Edition);2/17/2007, Vol. 334 Issue 7589, p369 

    The article presents opinion on methods that could be used by medical institutions and governments worldwide to help make the price of new drugs more fair to consumers. Arguments are presented that suggest pharmaceutical companies place prices on new drugs which have no relation to their actual...

  • Plenty of green in gray market. MAY, DAVID // Modern Healthcare;10/17/2011, Vol. 41 Issue 42, p25 

    The author asserts that as providers are confronting shortages of drugs of all types, including chemotherapy agents, they have become increasingly troubled by the increasing costs. He says that the problems are attributed to companies responsible for creating and perpetuating the drug shortages....

  • Generic medicine a 'sweeter' pill to swallow.  // Finance Week;9/14/2001, p44 

    Focuses the use of generic medicines for the reduction of the cost of medical care in South Africa. Impact of the allotted budget of the government on ethical and generic medicine price; Differential spending of the government on ethical and generic medicines; Beneficial influence of generic...

  • Report finds Rx spending will double in five years. Levy, Sandra // Drug Topics;6/18/2001, Vol. 145 Issue 12, p16 

    Forecasts that the 2001 prescription drug spending in the United States will double over the next five years. Chronic health conditions among middle-age people; Factors responsible for the growth in drug spending; Categories that represent more than half of the increase in costs.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics